Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C368937-30 30 µl (1 mg/ml) $255 
LS-C368937-100 100 µl (1 mg/ml) $299 
LS-C368937-200 200 µl (1 mg/ml) $351 
UBE3B Antibody - Immunohistochemical analysis of UBE3B staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected with HRP and DAB as chromogen. The section was then counterstained with hematoxylin and mounted with DPX.
UBE3B Antibody - Western blot analysis of UBE3B expression in HEK293T (A); Jurkat (B) whole cell lysates.
UBE3B Antibody - Immunohistochemical analysis of UBE3B staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected with HRP and DAB as chromogen. The section was then counterstained with hematoxylin and mounted with DPX.
UBE3B Antibody - Western blot analysis of UBE3B expression in HEK293T (A); Jurkat (B) whole cell lysates.
1 of 2
2 of 2

Polyclonal Rabbit anti‑Human UBE3B Antibody (Internal, IHC, WB) LS‑C368937

Polyclonal Rabbit anti‑Human UBE3B Antibody (Internal, IHC, WB) LS‑C368937

Antibody:
UBE3B Rabbit anti-Human Polyclonal (Internal) Antibody
Application:
IHC, IHC-P, WB
Reactivity:
Human
Format:
Unconjugated, Unmodified
Price
Catalog Number
$255
LS-C368937-30
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
UBE3B Rabbit anti-Human Polyclonal (Internal) Antibody
Application:
IHC, IHC-P, WB
Reactivity:
Human
Format:
Unconjugated, Unmodified

Specifications

Description
UBE3B antibody LS-C368937 is an unconjugated rabbit polyclonal antibody to human UBE3B (Internal). Validated for IHC and WB.
Target
Human UBE3B
Synonyms
UBE3B | Ubiquitin-protein ligase E3B | Ubiquitin protein ligase E3B
Host
Rabbit
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Modifications
Unmodified
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the central region of human UBE3B.
Epitope
Internal
Specificity
Recognizes endogenous levels of UBE3B protein.
Applications
  • IHC
  • IHC - Paraffin (1:100 - 1:200)
  • Western blot (1:500 - 1:1000)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Presentation
PBS, pH 7.3, 0.01% Sodium Azide, 30% Glycerol
Storage
Aliquot and store at -20°C for 1 year. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About UBE3B
Q7Z3V4 Q7Z3V4

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/18/2024